Macquarie Group LTD Genmab A/S Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Genmab A/S stock. As of the latest transaction made, Macquarie Group LTD holds 217 shares of GMAB stock, worth $5,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares

217

Previous 325 33.23%

Holding current value

$5,540

Previous $9,000 44.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.13 - $30.27 $2,714 - $3,269	-108 Reduced 33.23%	217 $5,000
Q1 2024 May 14, 2024	SELL	$26.43 - $32.77 $581 - $720	-22 Reduced 6.34%	325 $9,000
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $90.8 Million - $115 Million	-3,249,389 Reduced 99.99%	347 $11,000
Q3 2023 Nov 14, 2023	SELL	$35.27 - $42.24 $12.3 Million - $14.7 Million	-347,523 Reduced 9.66%	3,249,736 $115 Million
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $4.21 Million - $4.84 Million	112,627 Added 3.23%	3,597,259 $137 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $12.1 Million - $15 Million	347,437 Added 11.07%	3,484,632 $132 Million
Q4 2022 Feb 21, 2023	SELL	$33.8 - $47.06 $4.09 Million - $5.7 Million	-121,121 Reduced 3.72%	3,137,195 $133 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $8.86 Million - $105 Million	-280,994 Reduced 7.94%	3,258,316 $105 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $1.19 Million - $1.71 Million	-44,347 Reduced 1.24%	3,539,310 $115 Million
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $811,168 - $1.04 Million	-26,209 Reduced 0.73%	3,583,657 $130 Million
Q4 2021 Feb 11, 2022	SELL	$35.87 - $47.12 $18.9 Million - $24.8 Million	-526,081 Reduced 12.72%	3,609,866 $143 Million
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $899,515 - $1.05 Million	-21,649 Reduced 0.52%	4,135,947 $181 Million
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $137 Million - $185 Million	4,157,596 New	4,157,596 $170 Million

Others Institutions Holding GMAB

# of Institutions

232

Shares Held

48.5M

Call Options Held

6.8K

Put Options Held

27.6K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $16.8B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Genmab A/S Transaction History